Xenetic Biosciences is a biopharmaceutical company dedicated to advancing innovative cancer therapies. It specializes in developing personalized chimeric antigen receptor T cell (CAR T) treatments, targeting patient-specific tumor neoantigens using its proprietary XCART platform. The company also leverages its PolyXen drug delivery platform for partnerships with other pharmaceutical companies.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.